{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:50:30Z","timestamp":1776426630666,"version":"3.51.2"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009891","name":"International Society of Nephrology","doi-asserted-by":"crossref","award":["RES0033080"],"award-info":[{"award-number":["RES0033080"]}],"id":[{"id":"10.13039\/100009891","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>A core feature of universal health coverage is equitable access to affordable care not exposing people to financial hardship. This study aims to provide a global overview on availability and access to medications and health technologies for delivery of optimal kidney care. An international survey of stakeholders (clinicians, policymakers, and patient advocates) from countries affiliated to the International Society of Nephrology was conducted from July to September 2022 on availability of tools and services for all aspects of kidney care and access to essential medications. Of 167 participating countries (97.4% of the global population), there were significant disparities in kidney care funding and service availability. Only 5 (n = 1) and 10% (n = 4) of countries in Latin America and Africa, respectively, publicly funded non-dialysis CKD care free at the point of delivery, compared to73% (n = 16) in Western Europe. Public funding (and free at point of delivery) for medications for dialysis and kidney transplantation was available in only 24% (n = 39) and 30% (n = 50) of countries worldwide, with the proportion increasing in line with country income levels. There was reduced capacity for the management of CKD mineral bone disease in low-income countries (LICs) - serum parathyroid hormone was available in only 26% (n = 5) of LICs and the ability to administer non-calcium-based phosphate binders and cinacalcet was also very limited in LICs [16% (n = 3) and 5% (n = 1), respectively]. Nutritional services like oral supplements were accessible in 32% (n = 6) of LICs versus 97% (n = 61) of high-income countries. This study highlights significant gaps in the global methods of funding and availability of medications, capacity for kidney disease monitoring, and capacity to treat complications of kidney disease to improve outcomes. Achieving universal and equitable access to essential medications and health technologies for kidney care is vital to tackle the rapidly growing global burden of kidney disease.<\/jats:p>","DOI":"10.1371\/journal.pgph.0004268","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T18:36:23Z","timestamp":1739212583000},"page":"e0004268","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Global availability of medications and health technologies for kidney care: A multinational study from the ISN-GKHA"],"prefix":"10.1371","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4318-2030","authenticated-orcid":true,"given":"Dearbhla M.","family":"Kelly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika S. W.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zibya","family":"Barday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Arruebo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5199-3925","authenticated-orcid":true,"given":"Fergus J.","family":"Caskey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Damster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5005-909X","authenticated-orcid":true,"given":"Jo-Ann","family":"Donner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8015-9470","authenticated-orcid":true,"given":"Vivekanand","family":"Jha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2438-8401","authenticated-orcid":true,"given":"Adeera","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaomi","family":"Nangaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0846-3187","authenticated-orcid":true,"given":"Marcello","family":"Tonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3601-8395","authenticated-orcid":true,"given":"Feng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6545-9715","authenticated-orcid":true,"given":"Ikechi G.","family":"Okpechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aminu K.","family":"Bello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5491-3460","authenticated-orcid":true,"given":"David W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"pgph.0004268.ref001","unstructured":"International Society of Nephrology. The road to UHC: why integration of circulatory health interventions in primary care is essential. 2023 [cited 2024 Jul 8]. Available from: https:\/\/www.theisn.org\/blog\/2023\/10\/02\/the-gcch-position-paper-on-integrating-circulatory-health-interventions-into-primary-care-for-uhc-in-a-nutshell\/"},{"key":"pgph.0004268.ref002","unstructured":"European Kidney Health Alliance. A shared vision for improving organ donation and transplantation in the EU. 2019 [cited 2024 Jul 8]. Available from: http:\/\/ekha.eu\/wp-content\/uploads\/FINAL_Joint-Statement-of-the-Thematic-Network-on-Organ-Donation-and-Transplantation.pdf"},{"issue":"4S","key":"pgph.0004268.ref003","first-page":"S117","article-title":"KDIGO 2024 Clinical Practice Guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","journal-title":"Kidney Int"},{"issue":"5","key":"pgph.0004268.ref004","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ki.2015.230","article-title":"A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010","volume":"88","author":"KT Mills","year":"2015","journal-title":"Kidney Int"},{"issue":"7","key":"pgph.0004268.ref005","doi-asserted-by":"crossref","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease \u2013 a systematic review and meta-analysis","volume":"11","author":"NR Hill","year":"2016","journal-title":"PLoS One"},{"key":"pgph.0004268.ref006","unstructured":"World Bank. European Union. 2020 [cited 2022 Feb 24]. Available from: https:\/\/data.worldbank.org\/region\/european-union"},{"key":"pgph.0004268.ref007","doi-asserted-by":"crossref","first-page":"l5873","DOI":"10.1136\/bmj.l5873","article-title":"Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey","volume":"367","author":"AK Bello","year":"2019","journal-title":"BMJ"},{"issue":"11","key":"pgph.0004268.ref008","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members","year":"2013","journal-title":"Ann Intern Med"},{"issue":"10","key":"pgph.0004268.ref009","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD","volume":"23","author":"JL Babitt","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"pgph.0004268.ref010","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/MNH.0000000000000918","article-title":"Renal osteodystrophy: something old, something new, something needed","volume":"32","author":"V David","year":"2023","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"5","key":"pgph.0004268.ref011","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrneph.2013.21","article-title":"Anaemia management and mortality risk in chronic kidney disease","volume":"9","author":"WH H\u00f6rl","year":"2013","journal-title":"Nat Rev Nephrol"},{"issue":"19","key":"pgph.0004268.ref012","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1001\/jama.2021.4807","article-title":"Effect of treating hyperphosphatemia with lanthanum carbonate vs calcium carbonate on cardiovascular events in patients with chronic kidney disease undergoing hemodialysis: the landmark randomized clinical trial","volume":"325","author":"H Ogata","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"pgph.0004268.ref013","doi-asserted-by":"crossref","first-page":"e001480","DOI":"10.1161\/JAHA.114.001480","article-title":"Association of fluid retention with anemia and clinical outcomes among patients with chronic kidney disease","volume":"4","author":"S-C Hung","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"pgph.0004268.ref014","doi-asserted-by":"crossref","first-page":"100754","DOI":"10.1016\/j.xkme.2023.100754","article-title":"CKD-associated pruritus and clinical outcomes in nondialysis CKD","volume":"6","author":"JS Scherer","year":"2023","journal-title":"Kidney Med"},{"issue":"3","key":"pgph.0004268.ref015","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1016\/S2214-109X(23)00570-3","article-title":"An update on the global disparities in kidney disease burden and care across world countries and regions","volume":"12","author":"AK Bello","year":"2024","journal-title":"Lancet Glob Health"},{"issue":"18","key":"pgph.0004268.ref016","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.2017.4046","article-title":"Assessment of global kidney health care status","volume":"317","author":"AK Bello","year":"2017","journal-title":"JAMA"},{"key":"pgph.0004268.ref017","unstructured":"World Health Organization. Health systems strengthening. [cited 2024 Jul 8]. Available from: https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/topic-details\/GHO\/health-systems-strengthening"},{"issue":"2","key":"pgph.0004268.ref018","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.kisu.2017.08.001","article-title":"Global kidney health atlas (GKHA): design and methods","volume":"7","author":"AK Bello","year":"2017","journal-title":"Kidney Int Suppl (2011)"},{"issue":"1","key":"pgph.0004268.ref019","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.kisu.2019.11.002","article-title":"Framework for establishing integrated kidney care programs in low- and middle-income countries","volume":"10","author":"M Tonelli","year":"2020","journal-title":"Kidney Int Suppl (2011)"},{"issue":"11","key":"pgph.0004268.ref020","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1503\/cmaj.080351","article-title":"Guidelines for the management of chronic kidney disease","volume":"179","author":"A Levin","year":"2008","journal-title":"CMAJ"},{"issue":"6","key":"pgph.0004268.ref021","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.123.067584","article-title":"Estimated lifetime cardiovascular, kidney, and mortality benefits of combination treatment with SGLT2 inhibitors, GLP-1 receptor agonists, and nonsteroidal MRA compared with conventional care in patients with type 2 diabetes and albuminuria","volume":"149","author":"BL Neuen","year":"2024","journal-title":"Circulation"},{"issue":"5","key":"pgph.0004268.ref022","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.kint.2023.05.013","article-title":"Trends and perspectives for improving quality of chronic kidney disease care: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"104","author":"KU Eckardt","year":"2023","journal-title":"Kidney Int"},{"issue":"11","key":"pgph.0004268.ref023","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41581-023-00745-6","article-title":"Inequities in kidney health and kidney care","volume":"19","author":"R Vanholder","year":"2023","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"pgph.0004268.ref024","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ekir.2021.10.015","article-title":"Catastrophic health expenditure and distress financing among patients with nondialysis chronic kidney disease in Uddanam, India","volume":"7","author":"B Gummidi","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"2","key":"pgph.0004268.ref025","doi-asserted-by":"crossref","first-page":"e000256","DOI":"10.1136\/bmjgh-2016-000256","article-title":"Chronic kidney disease in low-income to middle-income countries: the case for increased screening","volume":"2","author":"C George","year":"2017","journal-title":"BMJ Glob Health"},{"issue":"12","key":"pgph.0004268.ref026","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/nep.13935","article-title":"Building optimal and sustainable kidney care in low resource settings: the role of healthcare systems","volume":"26","author":"IG Okpechi","year":"2021","journal-title":"Nephrology (Carlton)"},{"key":"pgph.0004268.ref027","first-page":"n1992","article-title":"Chronic kidney disease: summary of updated NICE guidance","volume":"374","author":"Guideline Committee","year":"2021","journal-title":"BMJ"},{"key":"pgph.0004268.ref028","unstructured":"World Health Organization. WHO model list of essential medicines - 23rd list; 2023. [cited 2024 Jul 8]. Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2023.02"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0004268","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T18:36:38Z","timestamp":1739212598000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0004268"}},"subtitle":[],"editor":[{"given":"Olivier J","family":"Wouters","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0004268","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]}}}